MRK
Merck & Co., Inc.
Stock
$148.69−0.09 (−0.06%)Close Sep 28, 2026
MRK's revenue for 2025 was $65.01 billion, up 1.3% from the year before.
From SEC filings, Latest filing: 10-Q, Aug 7, 2026
| Revenue (TTM) | YoY | 5-year CAGR |
|---|---|---|
| $66.57B | +4.6% | 9.4% |
| Revenue (TTM) | $66.57B |
|---|---|
| YoY | +4.6% |
| 5-year CAGR | 9.4% |
Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $65.0B | +1.3% |
| 2024 | $64.2B | +6.7% |
| 2023 | $60.1B | +1.4% |
| 2022 | $59.3B | +21.7% |
| 2021 | $48.7B | +17.3% |
| 2020 | $41.5B | +6.1% |
| 2019 | $39.1B | −7.5% |
| 2018 | $42.3B | +5.4% |
| 2017 | $40.1B | +0.8% |
| 2016 | $39.8B | — |
| 2010 | $46.0B | +67.7% |
| 2009 | $27.4B | +15.0% |
| 2008 | $23.9B | −1.4% |
| 2007 | $24.2B | — |